Argos Therapeutics, Inc.

549300KNKIS8SF7WPH35

The entity

Status: Active
LEI status: Lapsed - not renewed
Category: Company
Legal form: Corporation (XTIQ)
Jurisdiction: US-DE
Entity created: July 28, 2013

Address

Country: United States
Legal address: C/O Corporation Service Company, 251 Little Falls Drive19808 WilmingtonUnited States (US-DE)
Head office: 4233 Technology Drive27704 DurhamUnited States (US-NC)

Identifier

LEI: 549300KNKIS8SF7WPH35
Registered: February 9, 2016 at 02:18 AM UTC
Last updated: August 12, 2026 at 07:26 PM UTC
Next renewal: March 21, 2019 at 12:31 AM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 2749040
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 2749040
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: The accounts are not published

Machine access

REST: https://lei.online/v1/entities/549300KNKIS8SF7WPH35This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search